Most Recent

image: Genome Digest

Genome Digest

By | December 5, 2014

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Layoffs, Restructuring at GSK

Layoffs, Restructuring at GSK

By | December 4, 2014

GlaxoSmithKline is eliminating 900 US jobs—most in R&D.

0 Comments

image: Royal Remains Confirmed

Royal Remains Confirmed

By | December 3, 2014

Bones unearthed in 2012 are likely those of King Richard III, a new DNA analysis shows.

0 Comments

image: Enzyme Design

Enzyme Design

By | December 3, 2014

Researchers create synthetic enzymes in the lab, encoded by artificial genetic material.

1 Comment

image: 23andMe Expands to U.K.

23andMe Expands to U.K.

By | December 2, 2014

British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.

1 Comment

image: A New Breed

A New Breed

By | December 1, 2014

Genomics and advanced reproductive technologies have turned cattle breeding into a whole new animal.

0 Comments

image: Cannabis Biotech

Cannabis Biotech

By | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.

2 Comments

image: Clone Wars

Clone Wars

By | December 1, 2014

Watch scenes from the 2013 World Dairy Expo, where KHW Regiment Apple-Red-ET won the reserve championship while her clone took home the grand championship.

1 Comment

image: Desktop Human

Desktop Human

By | December 1, 2014

Meet the researchers behind ATHENA, the project that aims to create a system of linked model human organs that may revolutionize drug development.

0 Comments

image: Homo Minutus

Homo Minutus

By | December 1, 2014

A miniature platform with multiple organ-on-a-chip constructs aims to speed up drug discovery—and create better transplants for patients.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech